SOUTH SAN FRANCISCO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Today Trishula Therapeutics, Inc., a clinical stage, privately held company developing TTX-030, a first-in-class anti-CD39 antibody in ...

SOUTH SAN FRANCISCO, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Today Trishula Therapeutics, a clinical stage, privately held company, was launched to be solely dedicated to the development of TTX-030, ...

Trentar last week announced that it has acquired a controlling stake with Trishula, a startup in the UAV propulsion system sector. Trentar recently acquired GarudaUAV, a leading drone-based services ...

SOUTH SAN FRANCISCO, Calif., Sept. 16, 2024 /PRNewswire/ -- Trishula Therapeutics, Inc., a clinical stage, privately held biotechnology company, today reported final results from a Phase 1 trial of ...

SOUTH SAN FRANCISCO, Calif., April 12, 2022 /PRNewswire/ -- Trishula Therapeutics, Inc., a clinical stage, privately held company developing TTX-030, a first-in-class investigational anti-CD39 ...

Trentar Pvt Ltd has recently announced that it has acquired a 75% stake in Hyderabad-based Trishula, a UAV propulsion system startup. “This acquisition will focus on making India independent and ...

Indian Author & Explorer Creates History: First Indian to Cover All 36 States and All 7 Continents ...